Description |
1 CD-ROM (PDF file (xvii, 217 pages : illustrations) ; 12 cm |
|
4 3/4 in |
Summary |
Live recombinant influenza viruses were successfully used as HIV vaccine vectors in a mouse model. Following intranasal prime-boost vaccination, HIV-specific CD8+ T cell responses were detected in the spleen, broncho-alveolar lavage, mediastinal and inguinal lymph nodes. HIV+α4β7+ CD8+ T cells contributed to protection in pseudo-challenge experiments using recombinant vaccinia virus expressing HIV antigens. This research highlights the importance of mucosal CD8+ T cells in viral immunity and emphasizes the need for additional studies to provide key insights to underpin future vaccine development |
Notes |
Submitted to the School of medicine in the Faculty of Health, Deakin University |
|
Thesis (Ph.D.) -- Deakin University, Victoria, 2015 |
Bibliography |
Bibliography: 160-210 pages |
Subject |
AIDS vaccines.
|
|
HIV antibodies.
|
|
Influenza viruses.
|
Genre/Form |
Academic theses.
|
Author |
Deakin University. Faculty of Health
|
|
Deakin University. School of Medicine, degree granting institution
|
|